ViroGates Financials
| VIRO Stock | 9.00 0.25 2.70% |
ViroGates |
| Foreign Associate | Croatia |
| Instrument | Denmark Stock View All |
| Exchange | Copenhagen Exchange |
| ISIN | DK0061030574 |
| Business Address | BanevAenget 13, Birkerd, |
| Sector | Healthcare |
| Industry | Medical Devices |
| Benchmark | Dow Jones Industrial |
| Website | www.virogates.com |
| Phone | 45 21 13 13 36 |
You should never invest in ViroGates without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of ViroGates Stock, because this is throwing your money away. Analyzing the key information contained in ViroGates' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
ViroGates Key Financial Ratios
ViroGates' financial ratios allow both analysts and investors to convert raw data from ViroGates' financial statements into concise, actionable information that can be used to evaluate the performance of ViroGates over time and compare it to other companies across industries.ViroGates Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining ViroGates's current stock value. Our valuation model uses many indicators to compare ViroGates value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ViroGates competition to find correlations between indicators driving ViroGates's intrinsic value. More Info.ViroGates AS is rated first in return on equity category among its peers. It is rated first in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value ViroGates by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for ViroGates' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.ViroGates AS Systematic Risk
ViroGates' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. ViroGates volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Illegal number of arguments. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on ViroGates AS correlated with the market. If Beta is less than 0 ViroGates generally moves in the opposite direction as compared to the market. If ViroGates Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one ViroGates AS is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of ViroGates is generally in the same direction as the market. If Beta > 1 ViroGates moves generally in the same direction as, but more than the movement of the benchmark.
ViroGates March 1, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of ViroGates help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of ViroGates AS. We use our internally-developed statistical techniques to arrive at the intrinsic value of ViroGates AS based on widely used predictive technical indicators. In general, we focus on analyzing ViroGates Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build ViroGates's daily price indicators and compare them against related drivers.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 32.29 | |||
| Value At Risk | (8.78) | |||
| Potential Upside | 9.73 |
Other Information on Investing in ViroGates Stock
ViroGates financial ratios help investors to determine whether ViroGates Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ViroGates with respect to the benefits of owning ViroGates security.